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   INTRODUCTION 
 
  The yellow oleander (Thevetia Peruviana) is an ornamental tree, 
which is common throughout the tropics and subtropics. It contains cardiac 
glycosides that are toxic to cardiac muscle and the autonomic nervous system. 
Deliberate ingestion of oleander seeds has become a popular method of self-
harm in India. 
 Ingestion of oleander seeds results in a clinical picture similar to that of 
digoxin overdose. Severely poisoned patients may die in dc shock resistant 
ventricular fibrillation.  Severe Hyperkalemia is a feature of acute oleander 
poisoning, which may further worsen toxicity and lead to serious Arrhythmias.  
 So, it was decided to study the yellow oleander poisoning in our place 
regarding the clinical profile, ECG changes and Electrolytes changes which 
decides the mortality and modification of which would improve the prognosis 
in our patients. 
 
 
 
 REVIEW OF LITERATURE 
            Oleander is an ornamental tree of the Apocyanaceae family that is 
common throughout the tropics and subtropics.1 It is wide spread in India, 
Nepal and Srilanka. Its flowers are used as offerings in the temple. Its sap 
contains cardiac glycosides (thevetins A and B and neriifolin)  including the 
roots and the smoke produced from burning,  toxic  to  cardiac  muscle  and  the 
ingestion of its seeds results in a clinical picture similar to that of digoxin 
overdose.3-5 . Oleander leaf also contains other biologically active constituents 
that have antimitotic and insecticidal properties. Oleander is also reported to 
have emetogenic, cathartic, insecticidic, parasiticidic, anthelmintic, menstrual 
stimulant, and abortifacient activities30.  
The majority of deaths occurring after ingestion of plant are due to 
yellow Oleander or ‘pila kaner’ (cerebra thevetia), pink eyed cerebra or ‘sea 
mango’ (cerebra manghas), and white oleander or ‘kaner’ (nerium odorum) are 
reported in South India. Poisoning with another related plant cerebra odollum is 
a common occurrence in Kerala with as many as 50% of the plant poisoning 
caused by this plant14.  
 
Adults have died after consuming oleander leaves in herbal teas.8 
Accidental poisonings occur throughout the tropics particularly in children2 6 7.  
Many patients with moderate poisoning show PR interval prolongation and 
progression to atrioventricular (AV) dissociation. Severely poisoned patients 
may die due to dc shock resistant ventricular fibrillation. However, deliberate 
ingestion of yellow oleander seeds has recently become a popular method of 
self harm 9 10. 
PATHOPHYSIOLOGY 
                  More than 200 naturally occurring cardiac glycosides have been 
identified. The seed contains four percent of the thevetin, which is one-eighth 
as potent as ouabin and similar to digitalis in action; thevetoxin is similar to but 
less toxic than thevetin; nerifolin(more potent than thevetin); peruvoside, and 
ruvoside, cerberin and also bitter principle that acts on the CNS, and produce 
tetanoid convulsions.11  
 
Fig 1: Molecular structure of oleanderin. 
  
 
Fig 2: Mechanism of action of cardiac glycosides                           
(ATPase = adenosine triphosphatase). 
 
          These bind to a site on the cell membrane, producing reversible 
inhibition of the sodium (Na+)-potassium (K+)-adenosine triphosphatase 
(ATPase) pump, which causes increased intracellular sodium and decreased 
intracellular potassium. In myocytes, elevated intracellular sodium 
concentrations produce increased intracellular calcium concentrations via a Na+ 
-calcium (Ca++)-exchanger. In response to the increased intracellular calcium, 
the sarcoplasmic reticulum releases additional calcium intracellularly resulting 
in depolarization of the celll2. 
             Cardiac glycosides also have vagotonic effects, resulting in bradycardia 
and heart blocks. 
The pathophysiology that produces cardio toxicity involves prolonging 
refractory period in atrioventricular (AV) node, shortening refractory periods in 
atria and ventricles, and decreasing resting membrane potential (increased 
excitability). At therapeutic doses, cardiac glycosides also may increase 
inotropy. Any dysrhythmia characterized by both increased automaticity and 
depressed conduction is suggestive of cardiac glycoside toxicity. 
Inhibition of Na+ -K+ -ATPase in skeletal muscle results in increased 
extra cellular potassium and contributes to hyperkalemic state, which may lead 
to arrhythmias and death13. 
Lethal dose 
Previously suggested that the lethal dose was between four and seven 
seeds.  
 But, even the ingestion of 1–2 seeds by a young child is more 
dangerous, since small amounts of seeds may not always induce vomiting.  
Recent studies show that there is no simple relationship between the 
number of seeds ingested and outcome.  
So we have to monitor the degree of poisoning by following the cardiac 
rhythm rather than infer from the number of seeds taken28-29. 
CLINICAL FEATURES 
 The symptoms start within 2-3 hours of ingestion11. Oleander may cause 
irritation to the mucosal membranes, resulting in burning sensation around the 
mouth and increased salivation.  
The cardiac glycosides in oleander produce more gastrointestinal effects 
than those in digoxin, and the symptoms range from nausea and vomiting to 
cramping and bloody diarrhea39.  
Confusion, dizziness, drowsiness, weakness, visual disturbances, 
mydriasis and convulsions are central nervous system manifestations of 
toxicity2-6. 
 The most serious side effects of oleander poisoning are cardiac. 
Bradycardia and heart block are the most frequently reported cardiac 
abnormalities. Various ventricular dysrhythmias and tachyarrhythmias have 
been described.3-5, 7-9. 
The time course and outcome was also quite variable. It also depends 
upon the form of the seeds they consumed. In SriLanka peoples usually eat the 
seeds as a whole, which probably reduces the bioavailability of the cardiac 
glycosides. 
 But in south India peoples crush the seeds and drink, from which the 
cardiac glycosides might be more quickly absorbed. 
Patients may be in Sinus Rhythm for quite long period before developing 
serious Arrhythmias. So it’s important to monitor all the patients at least for 48 
hrs30.  
ECG CHANGES  
The most common arrhythmias were conduction defects affecting  
Sinus node  
• Sinus bradycardia - 25% 
• Sinus arrest or exit block - 62% 
AV node  
• First, Second and third degree heart block - 53%. 
Both sinus and AV nodes - 30%16.
 
Mobitz type II AV conduction block occurred in the oleander patients, 
but rare in isolated digoxin poisoning24,40.  
 Atrial fibrillation and flutter were uncommon in oleander patients, 
probably because of their good pre-existing cardiac status. Patients with these 
arrhythmias presented with a slow ventricular response owing to impaired AV 
conduction, as occurs in digoxin poisoning.
  Ventricular ectopic beats were uncommon in the oleander patients. 
ELECTROLYTES 
 Hypokalemia worsens toxicity due to digitalis glycosides, and 
hyperkalemia is life threatening. Both must be corrected. Hyperkalemia is due 
to extra cellular shift of potassium rather than an increase in total body 
potassium, and is a marker of a poor outcome in cardiac glycoside poisoning. 
 Even though all symptomatic patients had persistent vomiting, severe 
yellow oleander induced cardio toxicity was associated with hyperkalaemia. 
The degree of hyperkalaemia correlated with the serum digoxin cross reactive 
cardiac glycoside concentration25. 
Intravenous calcium increases the risk of cardiac arrhythmias and is not 
recommended in treating hyperkalemia. Oral or rectal administration of sodium 
polystyrene sulfonate resin may result in hypokalemia when used together with 
digoxin-specific antibody fragments. 
 Unlike digoxin toxicity, serum magnesium concentrations are less likely 
to be affected in yellow oleander poisoning. The effect of magnesium 
concentrations on toxicity and outcome is not known. Hypomagnesaemia 
should be corrected as it can worsen cardiac glycoside toxicity. 
SERUM CARDIAC - GLYCOSIDES 
The cross-reactivity seen between digoxin radioimmunoassays and the 
glycosides of oleander is well known. This cross-reactivity can at least identify 
the presence of a cardio active glycoside in the case of an unknown poisoning.  
Beyond its qualitative usefulness in oleander toxicity, the digoxin serum 
level's clinical significance is unknown. The digoxin radioimmunoassay is not 
specific for all of the glycosides that may be present in the oleander plant16-23. 
The use of a digoxin radioimmunoassay in oleander toxicity will only 
indicate the presence of glycoside and may not indicate the degree of toxicity. 
There was no apparent relation between the site of conduction block and 
the serum cardiac glycoside or electrolyte values. However, the mean  
Serum cardiac glycoside concentration was significantly higher in patients with 
both AV and sinus node block than in patients with block affecting only the 
sinus node25. 
 
 
 
TREATMENT 
PREHOSPITAL CARE  
• Prehospital care should focus on ABCs, with special emphasis on 
supporting respiratory and cardiac function.  
• During transport, the patient should receive supplemental oxygen and an 
IV line. Cardiac and pulse oximeter monitoring should be continuous.  
• In patients with protected airway and normal mental status, activated 
charcoal can be administered.  
• Atropine should be given to patients with clinically significant bradycardia 
(e.g., hypotension, change of mental status).  
EMERGENCY DEPARTMENT CARE 
The treatment of oleander poisoning is empirically based on the 
treatment of digitalis-glycoside toxicity and consists of supporting the patient 
hemodynamically. 
No definite criteria are available for risk stratification 
PREVENT FURTHER ABSORPTION  
 STOMACH WASH AND MULTI-DOSE ACTIVATED CHARCOAL 
 Activated charcoal is most effective when used soon after ingestion of 
the toxin.  
It interrupts the enterohepatic circulation of the glycoside. But, not all 
the glycosides have enterohepatic circulation. 
 Activated charcoal prevents further absorption of the cardiac 
glycosides17. So, it increases the excretion of digoxin in humans.27,28
 Activated charcoal improves the outcome in oleander poisoning and 
reduces the need for expensive cardiac pacing and antidigoxin antibody Fab 
fragments. 
So administering activated charcoal is beneficial without any risk. 
Dosage - 50 g of activated charcoal every 6 h for 3 days. 
 
MONITORING OF SERUM LEVELS OF POTASSIUM AND 
TREATMENT OF FLUID, ELECTROLYTE AND ACID-BASE 
BALANCE  
 
HYPERKALEMIA:  
Life-threatening hyperkalemia (>6.5 mEq/L) may be seen with acute 
toxicity and results from a redistribution phenomenon rather than increased 
body stores.  
• Glucose, insulin, sodium bicarbonate, and albuterol may be used 
to    facilitate redistribution of potassium intracellularly. However, 
albuterol may precipitate cardiac dysrhythmias.  
• Calcium should be avoided. A recent study shows that, in contrast 
to earlier studies, IV calcium administration to treat hyperkalemia 
secondary  to cardiac glycoside toxicity resulted in no benefit or 
harm. However, it’s not recommended. 
•  Life-threatening hyperkalemia should be treated with Fab 
fragments. 
 
HYPOKALEMIA 
 
      Symptomatic or severe hypokalemia should be corrected with intravenous 
potassium preparations. 
Potassium supplements: 
       Potassium chloride (also citrate, acetate, bicarbonate, gluconate). 
       Potassium chloride is the preferred salt for patients with preexisting 
alkalosis and first choice for IV therapy.  
Adult Dose: 
IV replacement: 
      10-40 mEq IV infused over 2-3 h; infusion rate not to exceed 40 mEq/h; 
may be repeated q3-4h; Please modify infusion rate for specific requirements. 
 
 
 PO supplementation: 
    50-100 mEq/d PO divided bid/tid or qd as SR formulation; larger doses may 
be needed in severe depletion to replenish potassium body storage. 
Precautions 
         Do not infuse rapidly; high plasma concentrations of potassium may 
cause death due to cardiac depression, arrhythmias, or arrest; 
         Plasma levels do not necessarily reflect tissue levels; monitor potassium 
replacement therapy whenever possible by means of continuous or serial ECG;  
        IV potassium must be diluted before administration, when a concentration 
>40 mEq/L is infused, local pain and phlebitis also may follow. 
 
MONITORING THE CARDIAC RHYTHM. 
 This treatment may include, 
• Bradydysrhythmias:   Administering atropine for severe 
bradycardia. If atropine is not rapidly successful, consider use 
of isoproterenol, administration of Fab fragments and 
transcutaneous cardiac pacing. 
• Tachydysrhythmias: Phenytoin and lidocaine may be used as 
antidysrhythmics if Fab fragments are not immediately 
available (which decrease automaticity without slowing AV 
nodal conduction and increase fibrillation threshold) may be 
used to treat ventricular dysrhythmias.  
• Use cardioversion only as a last resort. It should be attempted 
after a loading dose of phenytoin and at a significantly reduced 
initial power setting of 5-10 J.  
• Quinidine and procainamide may enhance cardiac glycoside 
toxicity by slowing conduction across AV node; both should 
be avoided.  
• Beta-blockers and calcium channel blockers have questionable 
value14, 26.  
 
.ADMINISTER ANTIDOTE: Digoxin-specific Fab antibody fragments 
(Digibind) 
Sheep-derived digoxin antibody Fab fragments reportedly are effective 
for some plant cardiac glycosides. Digibind binds with an unknown portion of 
the total glycosides. Indications for digoxin antibody Fab fragments are the 
same for both pharmaceutical as well as nonpharmaceutical cardiac glycoside 
toxicity and include the following:  
• Hyperkalemia (>5.0 mEq/L) in acute toxicity  
• Life-threatening supraventricular and ventricular dysrhythmias  
• Hemodynamically significant bradycardia unresponsive to 
atropine  
• Chronic digoxin toxicity with dysrhythmias, significant GI 
symptoms, acute altered mental status, or renal insufficiency  
• Serum digoxin level >15 mg/mL at any time  
• Poisoning by nondigoxin cardiac glycoside  
• To aid in treatment of suspected cardiac glycoside poisoning 
without a confirmatory level  
Forced diuresis, hemoperfusion, and hemodialysis are ineffective in enhancing 
the elimination. 
 
 
 
 
 
 
 
 
 
 
 
INDICATIONS OF PACE MAKERS IN BRADY-ARRHYTHMIAS 
 
Table 1 Summary of Guidelines for Pacemaker Implantation in SA Node 
Dysfunction 
 
Class I 
  1. SA node dysfunction with symptomatic bradycardia or sinus pauses 
  2. Symptomatic SA node dysfunction as a result of essential long-term drug 
therapy with no acceptable alternatives 
  3. Symptomatic chronotropic incompetence 
Class IIa 
  1. SA node dysfunction with heart rates < 40 beats/min without a clear and 
consistent relationship between bradycardia and symptoms 
  2. SA node dysfunction with heart rates < 40 beats/min on an essential long-
term drug therapy with no acceptable alternatives, without a clear and 
consistent relationship between bradycardia and symptoms 
  3. Syncope of unknown origin when major abnormalities of SA node 
dysfunction are discovered or provoked by electrophysiologic testing 
Class IIb 
  1. Mildly symptomatic patients with waking chronic heart rates < 40 
beats/min 
Class III 
  1. SA node dysfunction in asymptomatic patients even those with heart rates 
< 40 beats/min 
  2. SA node dysfunction in which symptoms suggestive of bradycardia are not 
associated with a slow heart rate 
  3. SA node dysfunction with symptomatic bradycardia due to nonessential 
drug therapy 
 
Table 2 Guideline Summary for Pacemaker Implantation in Acquired AV 
Block 
 
Class I 
  1. Third-degree or high-grade AV block at any anatomic level associated 
with: 
    a. Symptomatic bradycardia 
    b. Essential drug therapy that produces symptomatic bradycardia 
    c. Periods of asystole > 3 s or any escape rate < 40 beats/min while awake 
    d. Postoperative AV block not expected to resolve 
    e. Catheter ablation of the AV junction 
    f. Neuromuscular diseases such as myotonic dystrophy, Kearns-Sayre 
syndrome, Erb dystrophy, and peroneal muscular atrophy, regardless of the 
presence of symptoms 
  2. Second-degree AV block with symptomatic bradycardia 
  3. Type II second-degree AV block with a wide QRS complex with or 
without symptoms 
Class IIa 
  1. Asymptomatic third-degree AV block regardless of level 
  2. Asymptomatic type II second-degree AV block with a narrow QRS 
complex 
  3. Asymptomatic type II second-degree AV block with block within or below 
the His at electrophysiologic study 
  4. First- or second-degree AV block with symptoms similar to pacemaker 
syndrome 
Class IIb 
  1. Marked first-degree AV block (PR interval > 300 ms) in patients with LV 
dysfunction in whom shortening the AV delay would improve hemodynamics 
  2. Neuromuscular diseases, such as myotonic dystrophy, Kearns-Sayre 
syndrome, Erb dystrophy, and peroneal muscular atrophy, with any degree of 
AV block regardless of the presence of symptoms 
Class III 
  1. Asymptomatic first-degree AV block 
  2. Asymptomatic type I second-degree AV block at the AV node level 
  3. AV block that is expected to resolve or is unlikely to recur (Lyme disease, 
drug toxicity) 31
 
 
 
 
 
 
 
 
 
 
 
 
 
                                      OBJECTIVES 
  To analyze the patients with acute yellow Oleander seed Poisoning with 
reference to- 
• Socio-demographic aspects 
• Clinical Profile 
• ECG Changes 
• Electrolyte Status and 
• Outcome. 
 
 
 
 
 
 
 
 
 
 
 
 
                                 MATERIALS & METHODS 
 
Setting: Poison Control, Training and research centre Govt.General Hospital 
& Madras   Medical College, Chennai.  
Design of Study: Descriptive Study. 
Duration: Jan 2009 to June 2009. 
Ethical Clearance: Obtained from appropriate authorities. 
Informed Contest: Obtained.  
 
DATA COLLECTION 
          Clinical parameters, CBC, Blood sugars, Serum Urea, Creatinine, Serum 
Na+, Serum K+, LFT, ABG, ECG, and Gastric aspirate analysis. 
  
 BRIEF PROCEDURE: 
All patients admitted with consumption of yellow oleander seed or its 
extracts within 48 hours were studied. The study was carried out over a six-
month-period beginning Jan 2009 to June 2009..A detailed history was 
obtained and patients were subjected to thorough clinical examination as well 
as  ECG soon after admission. They were assessed on a hourly basis for the 
first 6 hours, 12 th hourly for next 72 hours on then daily basis until complete 
recovery. Results of biochemical investigations including serum electrolytes 
will be entered in a pre-designed proforma. Serial ECGs was collected. 
Inclusion criteria: 
       Patients admitted to the toxicology ward within 48 hours of ingestion of 
poison. 
Exclusion criteria: 
1. Patients with history of cardiovascular disease 
2. Patients on cardiac drugs. 
3. Patients with chronic renal failure.  
4. Patients on diuretics. 
                            
 
 
 
 
 
 
 
 
 
                                        RESULTS 
Epidemiological pattern of Oleander Seed Poisoning in poison centre, 
Govt.General Hospital 
             
Fig: 3 
 
 
 
 
 
Table : 3 
 
SI NO Age Group Frequency(n) Percentage(%) 
1 <20 20 27.77 
2 21-30 43 59.72 
3 31-40 4 5.55 
4 41-50 4 5.55 
5 >50 1 1.38 
 
Majority of the patients were in 21-30 age groups. The number of people 
between the age group of 14-30 accounts for 85%. 
 
Fig : 4 
 
 
 
 
 
 
Table : 4 
 
 
 
SI No Age Group Frequency(n) Death Percentage(%)
1 <20 20 1 1.4 
2 21-30 43 2 2.7 
3 31-40 4 1 1.4 
4 41-50 4 0 0 
5 >50 1 0 0 
 
Three people in the age group of below thirty died. 
 
 
 
 
 
Fig: 5 
 
 
 
 
 
 
Table : 5 
 
 
SI NO Sex Frequency(n) Percentage (%) 
1 Male 35 48.6 
2 Female 37 51.4 
 
 
Incidence of Oleander was almost equal in both genders 
 
 
 
 
 
 
 
 
Fig: 6 
 
 
 
 
 
 
 
 
 
Table: 6 
 
 
SI No Referral Frequency(n) Percentage (%) 
1 Referred 58 80.5 
2 Direct 14 19.5 
 
More than 80% of the patients with Oleander poisoning were referred. 
 
 
 
 
 
 
Fig: 7 
 
 
 
 
 
 
 
Table: 7 
 
 
SI NO Cases Frequency(n) 
1 Total 1335 
2 Oleander 72 
 
 
Oleander Seed poison cases accounted for 5% of the total Poison cases 
admitted. 
 
 
 
 
 
 
Fig: 8 
 
 
 
 
 
 
 
Table: 8 
 
 
SI NO ECG Frequency(n) Percentage (%) 
1 Normal 27 37.5 
2 Abnormal 45 62.5 
 
 
More than 60% of the patients with Oleander poisoning had abnormal ECG’s. 
 
 
 
 
 
 
Fig: 9 
 
 
 
SA Block- Sino-Atrial Block, I HB- I Degree Heartblock, 
CHB- Complete Heart Block. 
 
Table: 9 
 
SI No ECG Changes Frequency(n) Percentage(%) 
1 Normal 27 37.5 
2 Sinus Bradicardia 12 16.6 
3 Sino-Atrial Block 8 11.11 
4 I Degree Hear Block 9 12.5 
 
5 
II Degree Heart Block 
Mobitz Type I 
Mobitz Type II 
  
4 
4                        
 
5.5 
5.5 
6 Complete heart block 1 1.3 
7 Idioventricular Rhythm 1 1.3 
8 Junctional Rhythm 6 8.3 
Fig: 10 
 
 
Table: 10 
SI No ECG Changes Frequency(n) Death Percentage(%)
1 Normal 27 0 0 
2 Sinus Bradi 12 0 0 
3 SinoAtrial 
Block 
8 0 0 
4 I HB 9 0 0 
 
5  
II Degree Heart 
Block 
Mobitz Type I 
Mobitz Type II 
 
 
4 
4 
 
 
0 
2 
 
 
0 
2.7 
6 Complete heart 
Block 
1 1 1.38 
7 Idioventrricular 
Rhythm 
 
1 
 
1 
 
1.38 
8 Junctional 
Rhythm 
6 0 0 
Among the four patients who died two of them had II Degree Heart 
Block (Mobitz type II), one had Idioventricular Rhythm and last one had 
complete heart block. 
Table 11:  Bio Chemistry Values 
 
 
SI.No 
 
 
Values 
 
Mean 
 
S.D(+/-) 
 
1. 
 
 
Blood Sugar 
mg/dl 
 
115.94 
 
70.82 
 
2. 
 
 
Urea mg/dl 
 
24.97 
 
9.15 
 
3. 
 
 
Creatinine 
 
0.85 
 
6.18 
 
4. 
 
 
Sodium 
 
125.54 
 
8.20 
 
 
Table 12: Liver Function Test 
 
SI.No 
 
 
Values 
 
Mean  
 
S.D(+/-) 
 
1. 
 
 
Serum Bilirubin 
 
0.72 
 
0.10 
 
2. 
 
 
AST 
 
24.24 
 
14.32 
 
3. 
 
 
ALT 
 
22.4 
 
10.0 
 
4. 
 
 
Total Protein g/dl 
 
6.5 
 
0.50 
Fig : 11 
 
 
 
 
 
 
 
Table: 13 
 
 
SI NO K+ Changes Frequency(n) Percentage(%) 
1 <=3.5 6 8.4 
2 3.6-5.5 51 71.8 
3 >5.5 14 19.7 
 
 
 
Hyperkalemia presented in 19.44% of the patients with Oleander Seed 
Poisoning. 8.4% had Hypokalemia. 
 
 
 
 
 
Fig: 12 
 
 
 
 
 
Table: 14 
 
 
SI NO K+ Levels Frequency(n) Death Percentage(%)
1 <=3.5 6 0 0 
2 3.6-5.5 51 0 0 
3 >5.5 14 3 21.43 
 
Because of early death (with in 35 min), serum electrolytes could not be 
measured, in one among the four patients who expired. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig: 13 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig: 14 
 
 
 
 
 
 
 
Table : 15 
 
 
SI NO Outcome Frequency(n) Percentage(%) 
1 Recovered 68 94.4 
2 Expired 4 5.6 
 
 
Mortality rate among those who consumed Oleander seed as a poison was 
5.6%. 
 
 
 
 
 
 
 
Tab 16:  Analysis of Cases Expired 
 
 
 
 
Case No. 
 
 
Duration of Stay 
in Hrs 
 
ECG Changes 
 
Number of    
Seeds 
 
     1 
 
       7 
 
Idioventricular 
Rhythm 
 
 
       3 
 
     2 
 
 
      48 
 
Mobitz Type II 
 
       4 
 
     3 
 
 
      4 
 
Mobitz Type II 
 
       4 
 
     4 
 
 
    35 Min 
 
Complete heart 
block 
 
       10 
 
 
 
 
 
 
 
 POSTMORTEM CHANGES 
 
Postmortem was conducted to one patient it showed. 
 Section from heart shows normal cardiac muscle fibrosis with 
intervening interstium showing areas of hemorrhage. No evidence of coagulate 
necrosis is seen. 
 Section from aorta shows thickened media and adventia showing 
congested blood vessels. 
 Section from brain shows mild edema and congested blood vessels. 
 Section from liver shows sinusoidal congestion. 
Section from kidney shows normal glomeruli with congestion of 
interstium; no significant tubular changes are seen. 
 
 
 
 
 
 
 
DISCUSSION 
Comprehensive analysis of 72 cases of acute yellow oleander seed poisoning. 
EPIDEMIOLOGY OF ACUTE YELLOW OLEANDER SEED 
POISONING 
Age pattern 
 In this series of 72 cases, the number of the patients  below 20 years of 
age were 19(26%), between 21-30 were 42(58%) and remaining were 11(16%). 
In Thanjavur by Bobby et al, number of patients below age group of 20 was 
41.17% and between age group of 21-30 was 37.25% and remaining were 
23%38. Eddleston et al of SRILANKA revealed that age range 12-77 years, 
median 21 years25, 27, 29, 37. The series reported in this study had the similar 
pattern of age group affection. The reason could be that this age group by all 
probability is vulnerable to various emotional conflicts that occur during 
demanding phase of life. This young age group affected by exposure forms the 
viable entity of any population both in terms of procurement and productivity. 
This case study and the case reports mentioned above throw light on the target 
age group for educative and preventive programs to reduce the incidence of 
oleander seed poisoning. 
 
 
 
 SEX DISTRIBUTION 
 In poison center GGH Chennai females were exposed slightly more than 
male’s population (51.4% versus 48.6%). In observation of 52 cases in 
Thanjavur by Bobby et al revealed that female (32), male (19) 38. On the 
contrary in Srilanka by Eddleston et al in the observation of 1939 cases 
admitted males were 1021 (52.7%)25,27,29,37. This variation was due to handling 
of poison by the respective sex in their respective locality. 
 
MORTALITY AND AGE 
 Overall mortality in this study was 5 (5.5%). In age group of below 20 
the mortality rate was 1(1.4%), between 20-30 was 2(2.7%) and 31-40 was 
1(1.4%). In Thanjavur by Bobby et al in the observation of 51 cases the 
mortality rate was 1(1.96%) in the age group of 20-3038. In Srilanka by 
Eddleston et al in the observation of the 1939 patients (4.8%) were died. On 
contrary to our study, in Srilanka people over 64 years old were 13.8 (95%) 
times more likely to die than those less than of 25 years25, 27, 29, 37. In our study 
the number of patients in the age group of more than 40 years was five and 
mortality was nil.  
 
 
  
MORTALITY AND SEX 
 The percentage of mortality in males (8.5%) was higher compared to the 
females (2.71%). In Srilanka by Eddleston et al also similar findings were 
observed, the female case fatality was (3.9% vs. male 5.7%) 25,27,29,37.  
 
MAGNITUDE OF POISONING 
In our Toxicology, GGH in the period of six months the Magnitude of 
the Oleander seed poisoning admitted was 72(5%) from the total number of 
poison cases (1335) admitted. In these 72 cases 58(80.5%) cases were referred 
from near by GH and PHC’s belonging to five districts (Chennai, 
Kancheepuram, Thiruvallur, vizhuppuram and Vellore). 
 
ECG ABNORMALITIES 
 Among the 72 patients, the significant ECG abnormalities were found in 
45(62.5%), 37.5% had normal rate and rhythm. In these 16.6% had Sinus 
Bradycardia, 12.5% and 11% respectively had II Degree Heart Block & I. 
Among the 11% of the II Degree Heart Block 5.5% with Mobitz Type II Block. 
1.3% had the complete Heart Block. 11.11% had SA block and 8.3% presented 
with Junctional rhythm. 1.3% had idioventricular rhythm and in our study, 
Ventricular ectopics and Bundle branch blocks were not found. In Srilanka by 
Eddleston et al was observed among 89 seriously ill patients, 53% had AV node 
conduction block, 62% had sinus node block; 30% had conduction block 
affecting both nodes, 1% had ventricular tachycardias and 8% had ventricular 
ectopics25, 27, 29, 37. In Thanjavur by Bobby et al, observed that 27 patients who 
had ECG abnormalities among the 51 patients, Sinus Bradycardia (59.25%), 
Sinus tachycardia(11.11%), T-wave inversion(7.4%), S-T depression(11.11%), 
SA Block(7.4%), I Degree Block(11.11%), II Degree Block(3.7%), and 
Ventricular Tachycardia(3.7%) 38. 
 
 
 
 
 
 
 
 
 
 
 
 ECG 1 
 
 
 
 
 
 
ECG 1:  shows Sinus Bradycardia (Heart Rate 50). 
 
 
 
 
 
 
 
ECG 2   
 
 
 
 
 ECG 2 shows Sino-Atrial (SA) block. (No P wave or QRS complex is 
recorded drops out of complete cardiac cycle). 
 
 
 
 
 
 
 
 
 
ECG 3 
 
 
 
 
ECG 3:  shows First Degree Heart Block (PR Interval more than 0.20s). 
 
 
 
 
 
 
ECG 4 
 
 
 
 
 
 
ECG 4:  shows Mobitz Type I AV Block (Progressive   lengthening of 
successive PR interval until P wave is not conducted) 36. 
 
ECG 5 
 
 
ECG   5:  Shows Mobitz Type II 2:1 AV Block. In this P-R intervals of all 
conducted supra ventricular impulses are constant but alternate P wave is not 
conducted 35. 
 
 
ECG 6 
 
 
ECG 6:  Shows similar finding as above ECG; Mobitz type II 2:1 AV Block. 
 ECG 7 
 
 
 
ECG 7:  Taken from the same patient of ECG 5 shows Accelerated 
Junctional   Rhythm (No proceding P waves, narrow QRS Complex, Rate 
75). 
  
 
 
ECG 8 
 
 
 
  
ECG 8:  Shows Accelerated Idio ventricular Rhythm (Frequent and wide 
QRS complexes not preceded by P waves 34. 
  
ECG 9 
 
 
 
 
 
 
 
 
ECG 9: shows evidence of Junctional Rhythm later reverted to Sinus 
Rhythm and shows ST-T changes similar as Digoxin effects ( Straight 
downward slope with terminal rise – mirror image of check mark ) 34,35. 
 
 
 
 
RENAL AND LIVER FUNCTION TEST 
 No significant abnormalities were found in Renal and Liver functions. 
Eddleston et al in Srilanka also noted similar observation25, 27, 29, 37. 
 
ELECTROLYTES 
 No significant change in Serum Sodium level was noted. But significant 
change in the Serum Potassium levels was noted in 28.1% of patients. In this 
19.7% had Hyper-Kalemia and 8.4% had Hypo-Kalemia. Among the 4 patients 
died in our series, 3 had Hyper-Kalemia.  Remaining one patient went to 
cardiac arrest immediately after admission; So Laboratory investigation could 
not be done. Similarly studies conducted in Ananthapura in Srilanka by 
Eddleston et al revealed that the ECG changes and the mortality were higher in 
those who had Hyper-Kalemia. But exact incidence was not given. 
 
MANAGEMENT 
 In 72 patients, except one all of them underwent stomach wash and 
Activated Charcoal treatment. In this, 8 patients presented with normal rate and 
rhythm, doesn’t need any active treatment. In the remaining 64 patients 7% of 
them required Ionotropic support, 15% required Isoprenaline support. 
Pacemaker support was given to 1 patient. 16% of the patients required 
management for Hyperkalemia, and 8% for Hypokalemia treatment. 
MORTALITY  
Overall mortality in our study was 4(5.5%). In the four patients who died 
in our study, 
• One had Mobitz type II block consumed 4 seeds, shifted 
14 hours after the consumption, and had a potassium level 
of 6 meq/l. 
• One had Mobitz type II block and complex Arrhythmias, 
consumed 4 seeds, shifted 22 hours after the consumption, 
and had the potassium level of 7 meq/l. 
• One had Junctional Rhythm with ST-T changes progressed 
to idioventricular rhythm with hypotension, consumed 3 
seeds, and shifted after 24 hours of consumption, had the 
potassium level of 5.7 meq/l. 
• One patient died because of Cardiac arrest with in 35 
minutes of admission, shifted after 15 hrs of consumption, 
consumed 10 seeds.  This patient had hypotension and 
complete heart block in ECG, which was taken in 
peripheral hospital prior to referral. Serum Electrolyte was 
not taken because of early death. 
Mortality observed by Eddleston et al in Srilanka was 4.8%25, 27, 29, 37. In 
Thanjavur by Bobby et al observed that mortality was 2% due to ventricular 
Tachycardia 38. So deliberate self-poisoning is an important problem in the 
developing world, where the case fatality rate is far higher than in industrialized 
countries — 20% vs. <1% in the UK.25
  One reason for this large difference is the lack of antidotes for many of 
the poisons mostly used in poor agricultural communities.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
1. Oleander seed is still used as a suicidal agent. 
2. Oleander plant is easily available as an ornamental plant in urban, semi-
urban and rural areas. 
3. Oleander seed poison is most prevalent in the 14-30 age groups.  
4. Incidence is almost equal among the genders. 
5. Death of patients was independent of the number of seeds they 
consumed. 
6. ECG abnormalities were found in majority of the individuals. 
7. Electrolyte disturbances (Changes in serum K+ levels) were found in 
significant proportion of the patients.  
8. Prognosis was poor among those who presenting with Hypo-tension, 
Electrolyte disturbances specially those with Hyperkalemia, and 
complex Arrhythmias. 
9. The arrhythmias produced by this poisoning may range from Sinus 
bradycardia to complete heart block. 
 
 
 
 
 
 
STRENGTHS AND LIMITATIONS:  
 
        
1. The limitations were single center study and children’s were not 
included. 
 
2. Serum cardiac Glycosides (Digoxin) levels were not tested for the     
patients. 
 
3. Anti Digoxin-AB treatment was not given 
 
 
 
 
 
 
 
 
 
 
 
RECOMMENDATIONS 
 ¾ Considering mortality and morbidity associated with Oleander 
poisoning, it may be recommended that the use of oleander as an 
ornamental plants be avoided. 
 
¾ As there are no standard guidelines with reference to the indication for 
temporary pacemaker in the management of Oleander induced 
arrhythmias at present, uniform guidelines have to be formulated. 
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NAME SEX AGE LOCATION  DOA T O A 
NO OF 
SEEDS  D O I T O I T S C 
R 
OR 
NOR
Alamelu F 22 Kancheepuram 7/3/2009 01.30 PM 3 Seeds 06/03/09 02.00 PM 24 Hrs R 
Anjali F 20 Chengalpat 19/01/2009 11.00 PM 4 Seeds 19/01/2009 10.00 AM 12 Hrs R 
kalaiselvi  F  18 kancheepuram  3/2/2009 10.30 PM 4 Seeds 02/02/09 04.00 PM 36 Hrs R 
kamakshi F, P 22 Kaladipet 9/2/2009 07.15 PM 1 Seed 09/02/09 02.00 PM 5 Hrs NR 
Kamakshi 1 F 18 Thiruvallur Dt 15/01/2009 04.00 PM 4 Seeds 15/01/2009 9.00 AM 7 Hrs R 
Loganayagi F 29 Thiruvallur Dt 15/02/2009 11.30 PM 1 Seed 15/02/2009 7.00 PM 4 Hrs R 
Sarawathi F 30 Chindadripet 16/01/2009 02.25 AM 1 Seed 16/01/2009 10.00 PM 4 Hrs NR 
Sathish M 19 Thiruvallur Dt 22/01/2009 01.24 PM 10 Seeds 22/01/2009 08.00 AM 6 Hrs R 
Sekar M 35 Thiruvallur Dt 11/2/09 2.15 PM 4 Seeds 10/02/09 03.00 AM 12 Hrs R 
Velankanni F 30 Egmore 9/1/2009 10.15 AM 1 Seed 09/01/09 9.00 AM 1 Hrs NR 
Ammu Rajalakshmi F 14 Pallavaram 11/03/09 05.00 PM 6 Seeds 11/03/09 09.30 Am 7 Hrs R 
Anjali F 18 kancheepuram Dt 4/4/2009 04.00 PM 4 seeds 03/04/09 3.00 PM 23 Hrs R 
Desinga Raja M 22 Thiruvallur Dt 27/02/2009 03.10 PM 1 Seed 26/02/2009 01.00 PM 36 Hrs R 
Gomathi F,P 21 Kancheepuram Dt 7/3/2009 08.30 PM 1 Seed 07/03/09 09.00 AM 12 Hrs R 
Lakshmi F 22 Thiruvallur Dt 5/4/2009 04.20 PM 2 Seeds 05/04/09 01.00 PM 3 Hrs R 
Purusothaman M 19 Kancheepuram Dt 19/03/2009 08.30 AM 8 Seeds 18/03/2009 02.00 AM 28 Hrs R 
RoseMary F 23 KK Nagar 10/3/09 09.00 PM 1 Seed 10/03/09 06.30 PM 2.30 Hrs R 
Samundi M 43 Thiruvallur Dt 4/4/2009 01.40 PM 3 Seeds 04/04/09 06.00 AM 7 Hrs R 
Seetha  F 18 Thambaram 18/02/2009 01.25 PM 2 Seeds 17/02/2009 07.00 AM 32 Hrs R 
Vimala F 19 Villupuram 4/4/2009 02.42 PM 4 Seeds 03/04/09 1.00 PM 25 Hrs R 
Anandhan M 26 Kancheepuram 25/02/2009 06.42 AM 10 Seeds 24/02/2009 4.00 PM 14 Hrs R 
Arul M 16 Kancheepuram Dt 22/03/2009 01.10 PM 4 Seeds 21/03/2009 03.00 PM 22 Hrs R 
Babu M 22 Chindadripet 5/3/2009 09.22 PM 4 Seeds 05/03/09 2.00 PM 7 Hrs NR 
Nirmala F 21 MGR Nagar 13/04/2009 02.20 PM 1 Seed 13/04/2009 08.00 AM 6 Hrs R 
Raja M 27 Kolathur 13/05/2009 02.30 PM 3 Seeds 13/05/2009 10.00 AM 4 Hrs NR 
Rajendran M 52 Villivakkam 13/04/2009 10.30 AM 4 Seeds 12/04/09 07.00 PM 15 Hrs R 
Rajesh M 23 kancheepuram Dt 27/02/2009 06.29 PM 8 Seeds 25/02/2009 03.14 PM 48 Hrs R 
Tamilselvi F 29 Chrompet 6/3/2009 09.15 PM 5 Seeds 06/03/09 10.00 AM 11 Hrs R 
Usha F 21 Ambattur Estate 10/4/09 01.50 AM 2 Seeds 09/04/09 03.00 PM 13 Hrs NR 
Vatchala F 45 kancheepuram Dt 25/03/2009 07.45 PM 2 Seeds 25/03/2009 11.30 AM 8 Hrs R 
Gajendran M 43 kancheepuram Dt 14/03/2009 09.05 AM 3 Seeds 14/03/2009 04.30 AM 5 Hrs R 
George M 33 Madhuranthagam 21/02/2009 11.10 PM 10 Seeds 21/02/2009 07.00 AM 16 Hrs R 
Kamatchi 2 F 31 Poonamalle 21/04/2009 01.50 AM 3 Seeds 20/04/2009 08.00 PM 14 Hrs NR 
Gokila F 20 Moongileri 26/02/2009 12.30 AM 10 Seeds 25/02/2009 10.00 AM 26 Hrs R 
Mohan M 22 Kancheepuram 15/04/2009 12.50 AM 6 Seeds 14/04/2009 09.00 PM 3 Hrs R 
 
 
Bhuvaneshwari 
 
F 25 Thiruvallur Dt 10/05/09 4.40 PM 3 Seeds 10/05/09 10.00 AM 6 Hrs R 
Bhuvaneshwari F 16 Arakkonam 3/1/2009 11.40 PM 4 Seeds 03/01/09 09.00 AM 14 Hrs R 
Dayalan M 30 Velachery 11/05/09 04.45 AM 3 Seeds 10/05/09 06.30 PM 11 Hrs NR
Gunasekar M 25 Kancheepuram 14/01/200
9 
01.00 AM 6 Seeds 13/01/2009 08.00 PM 5 Hrs R 
Kavitha F 17 Pallikaranai 27/04/200
9 
11.25 PM 1 Seed 27/04/2009 12.00 PM 11 Hrs NR
Kosalai F 17 Kancheepuram 6/1/2009 03.00 PM 1 Seed 29/04/09. 1.00pm 6hrs R 
Malar F 25 Kancheepuram Dt 10/02/09 03.40 AM 4 Seeds 09/02/09 09.00 AM 18 Hrs R 
Mari M 27 Kancheepuram 12/02/09 01.20 PM 4 Seeds 11/02/09 07.30 PM 17 Hrs R 
Manivannan M 20 Villupuram 25/01/200
9 
06.25 PM 4 Seeds 25/01/2009 07.30 AM 11 Hrs R 
Raja M 23 Mangadu 3/5/2009 03.10 AM 4 Seeds 02/05/09 05.30 PM 9 Hrs R 
Ramesh M 22 Thirunindravoor 18/02/200
9 
11.24 PM 1 Pulp of 
Seed 
18/02/2009 8.00 PM 3 Hrs NR
Sakthivel M 20 mount 10/06/09 12.24 PM 3 Seeds 10/06/09 09.00 AM 3 Hrs NR
Sarawathi F 30 Thiruvallur Dt 16/01/200
9 
02.10 AM 1 Seed 16/01/2009 08.00 PM 6 Hrs R 
Srinivasan M 25 Narthanarthapuram 7/2/2009 02.20 PM 4 Seeds 07/02/09 09.00 AM 5 Hrs R 
Subhalakshmi F 17 Thiruvallore 14/05/200
9 
12.15 PM 5 Seeds 13/05/2009 06.00 PM 18 Hrs R 
Suresh M 26 Thiruvallore 25/05/200
9 
08.20 PM Handfull of 
Seeds 
24/05/2009 08.20 PM 24 Hrs R 
Thirupathi M 27 Nanganallur 19/02/200
9 
12.46 AM 3 Pulp 18/02/2009 7.00 PM 5 Hrs R 
Udhayakumar M 20 St.Thomas Mount 2/5/2009 02.18 AM 3 Seeds 01/05/09 11.00 PM 3 Hrs NR
Vatchala F 18 Villupuram 8/3/2009 10.25 PM 5 Seeds 07/03/09 11.00 AM 35 Hrs R 
Velankanni F 27 Neelankarai 15/02/200
9 
10.30 PM 7 Seeds 15/02/2009 07.00 PM 3.30 
Hrs 
R 
Velmurugan M 22 Kancheepuram 7/5/2009 05.21 PM 10 Seeds 05/05/09 10.30 AM 48 Hrs R 
Viji F 17 Kotturpuram 12/06/09 05.11 PM 4 Seeds 08/06/09 06.30 PM 4 Days R 
Senthil M 20 Villupuram 5/4/2009 04.20 AM 4 Seeds 04/04/09 08.00 AM 20 Hrs R 
Gopi M 32 Anagapalli, 
Chennai 
21/05/200
9 
03.47 AM 7 Seeds 20/05/2009 07.00 PM 8 Hrs NR
PonMeenakshi F 24 thiruvallore 16/01/09 6.00 pm 5 Seeds 20/01/2009 3.00 pm 6hrs R 
Sathya F 18 kancheeuram 29/05/2009 3 Seeds 04/05/09 4.00pm 7 hrs R 
Senthil M 30 arakkonam 29/06/2009 4 Seeds 06/05/09 8.00am 2hrs R 
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62 90/70 99 25 1 125 5.9 1 36 40 6 7 Hrs D Y Yes 
92 90/60 105 37 1.1 135 4.9 1 53 27 6 4 Days  Y  
52 100/70 77 37 1 138 4.1 0.9 98 25 7 2 Days  Y  
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75 120/80 175 30 0.9 122 3.9 0.6 21 17 7 3 Days  Y  
64 110/80 88 20 0.8 140 4.5 1 31 27 7 2 Days  N  
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94 
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           35 Mins D Y   
90 120/70 79 26 0.6 149 3 1 18 14 7 2 Days  Y  
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42 13O/90 104 18 0.7 140 4.4 TB 50 32 6 4 Days  Y Yes
## 150/80 92 21 0.9 129 5.6 1 32 21 6 3 Days  Y  
70 120/80 103 20 0.9 128 5.4 1 18 20 6 3 Days  N  
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56 110/70 101 22 0.8 140 4.9 0.7 22 27 6 4 Days  N  
80 110/90 120 26 0.8 120 3.7 0.8 22 22 6 2 Days  N  
90 130/80 96 20 0.8 124 4 0.6 16 28 6 4 Days  Y  
60 110/70 89 28 0.8 131 4.1 1 23 16 6 2 Days  Y  
70 100/70 120 21 0.7 137 4.8 0.8 17 30 7 4 Days  N  
64 100/70 114 17 0.8 135 4.1 0.7 29 23 7 5 Days  N  
42 140/70 112 32 1.2 129 4 0.9 45 18 7 5 Days  Yes 
94 100/80 145 16 0.6 121 4.3 0.7 18 24 7 3 Days  N  
60 130/80 293 16 0.8 143 3.5 0.8 24 36 7 4 Days  Yes 
90 100/70 74 25 0.8 125 3.8 1 39 38 7 2 Days  N  
88 100/60 76 18 0.7 143 4 0.8 20 29 7 4 Days  N  
## 110/70 111 20 0.8 138
V.Hig
h 0.9 21 24 3 1 Day  Yes 
90 130/90 92 37 1.4 127 4.5 0.8 21 25 7 6 Days  Yes 
76 120/70 199 34 1.2 130 3.5 0.9 17 18 6 3 Days  Yes 
88 110/80 113 27 0.9 136 4 0.9 25 20 7 5 Days  yes 
82 170/110 82 18 0.6 131 3.5 1 28 ## 7 4 Days  Yes 
84 150/50 84 22 0.8 136 3.6 0.8 12 18 7 3 Days  N  
88 120/80 120 30 1.1 120 3.8 0.9 16 14 8 3 Days  N  
80 110/70 499 18 0.6 126 3.6 0.9 12 15 4 2 Days  Yes 
55 120/70 61 34 1.3 130 4 0.8 23 37 7 4 Days  N  
54 110/70 160 36 0.9 129 5.9 0.8 29 31 7 4 Days  yes 
54 110/70 86 30 1 129 5.6 0.9 36 18 7 3 Days  Yes 
90 140/80 120 37 1.2 130 3.7  25 25 7 3 Days  N  
54 110/80 96 25 0.7 135 3.9 1 33 20 7   yes 
70 120/80 132 24 0.8 134 3.6 0.8 34 20 6   yes 
90 110/70 111 34 1 128 3.6 0.8 36 16 6   yes 
 I.Dopamine I.kcl i.insulin Comments 
Yes  Yes Idioventricular Rhythym 
Yes   S B 
   S B 
 Yes  N 
   N 
 yes  S T 
   N 
   N 
   N 
   S T 
   I HB 
   Jn Rhythm,  I HB 
   N 
   N 
   N 
   S T 
   N 
   N 
   N 
Yes   Jn RH, II HB Type I block 
Yes  Yes MobitzII 
Yes  Yes I HB, F.S P, Jn.Rhythm, II HB 
   2:1 AV Block, Rate 45 
 yes  N 
 yes  S B 
Yes  Yes Int. 2:1 AV Block 
 yes  Jn.Rhythm with Capture Beats 
   I HB 
   I & II Degree Type 1 Block 
   N 
   N 
   CHB,Sinus Arrest 
 yes  S B 
Yes  yes II HB Type I &2:1 Variable Block, Int Jn.Rh 
   N 
   S B 
  Yes S B 
   N 
   S P 
   S B 
 Yes  N 
   S B 
   I.S P 
 Yes  N 
   S P 
   N 
   S T 
   N 
   S T 
   N 
   N 
 Yes  S P, I HB 
   N 
   S B 
   N 
   S B 
  Yes I HB 
   S B 
   I HB 
   S B 
   I HB 
 Yes  N 
   N 
 Yes  S B 
   N 
  yes II Degree Type 1 Block 
  yes F.S P, Varying RR int 
   N 
   Var. II Degree AV Block, F.S P
   S P 
   SP,I HB 
 
 
